Toward the prevention of group B streptococcal early onset sepsis: the importance of defining target populations and second-line antimicrobials in line with current guideline recommendations - 02/04/24
Doi : 10.1016/j.ajog.2023.12.017
Chikako Iwai, MPH 
Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan
Ryuji Sasaki, MD, MPH
Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan
Division of Pediatric Emergency and Transport Services, National Center for Child Health and Development, Tokyo, Japan
Takashi Yoshioka, MD, PhD
Department of Preventive Medicine and Public Health, School of Medicine, Keio University, Tokyo, Japan
Le texte complet de cet article est disponible en PDF.
| The authors report no conflicts of interest. |
© 2023
Elsevier Inc. Tous droits réservés.
Vol 230 - N° 4
P. e61 - avril 2024 Retour au numéro
Article précédent
- Reply to Time to rethink maneuvers to resolve shoulder dystocia?
- Tak Yeung Leung, So Ling Lau
- Throwing the spotlight on group B streptococcal early onset sepsis prevention: the importance of appropriate second-line antimicrobials
- Jia Ming Low, Jan Hau Lee, Henry P. Foote, Christoph P. Hornik, Reese H. Clark, Rachel G. Greenberg
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?